Tesamorelin
Growth Hormone · 10 mg fill · Research Peptide
A stabilized GHRH(1-44) analog carrying a trans-3-hexenoic acid modification, studied in growth-hormone-axis signaling.
Overview
Tesamorelin is a synthetic analog of human growth-hormone-releasing hormone, GHRH(1-44), modified at the N-terminus with a trans-3-hexenoic acid moiety that slows enzymatic degradation. It binds the GHRH receptor and is referenced across research on somatotropic-axis signaling and IGF-1 regulation. Supplied as a high-purity lyophilized preparation for in-vitro research use.
Specifications
- Sequence
- GHRH(1-44) analog · N-terminal trans-3-hexenoic acid conjugate
- Form
- Lyophilized powder
- Vial Size
- 10 mg
- Purity
- >99% (HPLC)
- Reconstitution
- Bacteriostatic water
- Storage
- −20°C · protect from light
- Documentation
- Batch-specific COA
Research applications
- GHRH-receptor binding and selectivity assays
- Somatotropic-axis and IGF-1 signaling research
- Peptide-stability and enzymatic-degradation studies
- Comparative GHRH-analog research
For research use only. This product is intended for laboratory and educational research purposes only. It has not been evaluated by the FDA and is not for human or veterinary consumption, diagnosis, treatment, or cure of any condition.
View in catalogOrdering, vial options and the cart live in the catalog view.